Search - tctmd.com

Displaying 481 - 500 of 504

Sort: Relevancy | Date

News Industry News

Hemostemix Enrolls 20th Participant and Treats 15th in International Clinical Trial for Critical Limb Ischemia

July 27, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Industry News

Cardiovascular Systems Completes Coast Study Enrollment

July 14, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Industry News

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

June 22, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Daily News

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

L.A. McKeown

January 12, 2015

News Daily News

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

L.A. McKeown

January 12, 2015

News Daily News

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

L.A. McKeown

January 12, 2015

Presentation TCT 2014

TCT 314: Prevalence Of Coronary Microvascular Dysfunction Amongst Patients with Chest Pain and Nonobstructive Coronary Artery Disease

Presenter: Thomas F. Luscher, Jaskanwal Sara

September 16, 2014

Presentation TCT 2014

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

Presenter: Stuart J. Pocock, William S. Weintraub, David J. Cohen, Jae-Sik Jang, MD

September 13, 2014

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Daily News

PCI Efficacy Unaffected by HIV Status

Yael L. Maxwell

July 07, 2014

News Daily News

Risk Score Predicts Long-term Mortality After PCI

Caitlin E. Cox

February 03, 2014

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Daily News

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Caitlin E. Cox

August 30, 2013

News Daily News

Most Hospital Readmissions Within 30 Days of PCI Unrelated to Index Procedure

March 28, 2013

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

Live Case Procedures Just as Safe as in Daily Practice

Caitlin E. Cox

February 21, 2012

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

Advertisement

Hemostemix Enrolls 20th Participant and Treats 15th in International Clinical Trial for Critical Limb Ischemia

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

Cardiovascular Systems Completes Coast Study Enrollment

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

ASCERT费用分析：CABG的费用高于PCI，但是其结果更好

ASCERT Cost Analysis: CABG More Expensive Than PCI but Offers Better Outcomes

Análisis de Gastos del ASCERT: CABG Más Caro que PCI pero con Mejores Resultados

TCT 314: Prevalence Of Coronary Microvascular Dysfunction Amongst Patients with Chest Pain and Nonobstructive Coronary Artery Disease

TCT 347: Assessment of Intravascular Ultrasound-Derived Minimal Lumen Area and Fractional Flow Reserve to Evaluate Functionally Significant Coronary Artery Disease: A Meta-analysis

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

PCI Efficacy Unaffected by HIV Status

Risk Score Predicts Long-term Mortality After PCI

Innovation in Intervention: Perspectives from Industry

FAME 2: FFR-Guided PCI ‘Economically Attractive’ vs. Medical Therapy Alone

Most Hospital Readmissions Within 30 Days of PCI Unrelated to Index Procedure

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Live Case Procedures Just as Safe as in Daily Practice

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content